FDA hands Bristol Myers a landmark approval in early-stage lung cancer after just five days - Endpoints News
3/7/2022 12:00:00 AM3 years 1 month ago
by Jason Mast
by Jason Mast
On Feb. 28, the FDA accepted Bristol Myers Squibb’s application for approval of a new use of blockbuster checkpoint inhibitor Opdivo and said it would make a decision by July 13. That estimate turned out to be conservative, to say the least. On Friday, just f…
On Feb. 28, the FDA accepted Bristol Myers Squibbs application for approval of a new use of blockbuster checkpoint inhibitor Opdivo and said it would make a decision by July 13. That estimate turned… [+2212 chars]
full article...